vs
德康医疗（DXCM）与先锋自然资源公司（PR）财务数据对比。点击上方公司名可切换其他公司
德康医疗的季度营收约是先锋自然资源公司的1.1倍（$1.3B vs $1.2B），先锋自然资源公司净利率更高（29.0% vs 21.2%，领先7.8%），德康医疗同比增速更快（21.6% vs -9.8%），过去两年德康医疗的营收复合增速更高（12.0% vs -3.0%）
德康医疗是美国跨国医疗保健企业，专注于研发、生产及销售糖尿病管理领域的连续血糖监测（CGM）系列系统。其全球总部及研发中心位于美国加利福尼亚州圣地亚哥，生产基地分布于美国亚利桑那州梅萨、马来西亚峇都交湾及爱尔兰戈尔韦郡阿斯里。
先锋自然资源公司总部位于美国得克萨斯州欧文市，主要从事油气勘探业务，运营覆盖二叠纪盆地Spraberry产区的克莱恩页岩区块，是该区域最大的土地权益持有方，2024年5月被埃克森美孚收购。
DXCM vs PR — 直观对比
营收规模更大
DXCM
是对方的1.1倍
$1.2B
营收增速更快
DXCM
高出31.4%
-9.8%
净利率更高
PR
高出7.8%
21.2%
两年增速更快
DXCM
近两年复合增速
-3.0%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.3B | $1.2B |
| 净利润 | $267.3M | $339.5M |
| 毛利率 | 62.9% | — |
| 营业利润率 | 25.6% | 23.1% |
| 净利率 | 21.2% | 29.0% |
| 营收同比 | 21.6% | -9.8% |
| 净利润同比 | 153.6% | 56.7% |
| 每股收益（稀释后） | $0.67 | $0.48 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DXCMPR
| Q1 26 | $1.3B | — | ||
| Q4 25 | $1.3B | $1.2B | ||
| Q3 25 | $1.2B | $1.3B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.0B | $1.4B | ||
| Q4 24 | $1.1B | $1.3B | ||
| Q3 24 | $994.2M | $1.2B | ||
| Q2 24 | $1.0B | $1.2B |
净利润DXCMPR
| Q1 26 | $267.3M | — | ||
| Q4 25 | $267.3M | $339.5M | ||
| Q3 25 | $283.8M | $59.2M | ||
| Q2 25 | $179.8M | $207.1M | ||
| Q1 25 | $105.4M | $329.3M | ||
| Q4 24 | $151.7M | $216.7M | ||
| Q3 24 | $134.6M | $386.4M | ||
| Q2 24 | $143.5M | $235.1M |
毛利率DXCMPR
| Q1 26 | 62.9% | — | ||
| Q4 25 | 62.9% | — | ||
| Q3 25 | 60.5% | — | ||
| Q2 25 | 59.5% | — | ||
| Q1 25 | 56.9% | — | ||
| Q4 24 | 58.9% | — | ||
| Q3 24 | 59.7% | — | ||
| Q2 24 | 62.4% | — |
营业利润率DXCMPR
| Q1 26 | 25.6% | — | ||
| Q4 25 | 25.6% | 23.1% | ||
| Q3 25 | 20.1% | 29.6% | ||
| Q2 25 | 18.4% | 24.8% | ||
| Q1 25 | 12.9% | 36.6% | ||
| Q4 24 | 17.0% | 32.8% | ||
| Q3 24 | 15.3% | 32.5% | ||
| Q2 24 | 15.7% | 36.5% |
净利率DXCMPR
| Q1 26 | 21.2% | — | ||
| Q4 25 | 21.2% | 29.0% | ||
| Q3 25 | 23.5% | 4.5% | ||
| Q2 25 | 15.5% | 17.3% | ||
| Q1 25 | 10.2% | 23.9% | ||
| Q4 24 | 13.6% | 16.7% | ||
| Q3 24 | 13.5% | 31.8% | ||
| Q2 24 | 14.3% | 18.9% |
每股收益（稀释后）DXCMPR
| Q1 26 | $0.67 | — | ||
| Q4 25 | $0.67 | $0.48 | ||
| Q3 25 | $0.70 | $0.08 | ||
| Q2 25 | $0.45 | $0.28 | ||
| Q1 25 | $0.27 | $0.44 | ||
| Q4 24 | $0.37 | $0.31 | ||
| Q3 24 | $0.34 | $0.53 | ||
| Q2 24 | $0.35 | $0.36 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $917.7M | $153.7M |
| 总债务越低越好 | — | $3.5B |
| 股东权益账面价值 | $2.7B | $10.3B |
| 总资产 | $6.3B | $17.9B |
| 负债/权益比越低杠杆越低 | — | 0.34× |
8季度趋势，按日历期对齐
现金及短期投资DXCMPR
| Q1 26 | $917.7M | — | ||
| Q4 25 | $917.7M | $153.7M | ||
| Q3 25 | $1.8B | $111.8M | ||
| Q2 25 | $1.2B | $451.0M | ||
| Q1 25 | $904.9M | $702.2M | ||
| Q4 24 | $606.1M | $479.3M | ||
| Q3 24 | $621.2M | $272.0M | ||
| Q2 24 | $939.2M | $47.8M |
总债务DXCMPR
| Q1 26 | — | — | ||
| Q4 25 | — | $3.5B | ||
| Q3 25 | — | $3.5B | ||
| Q2 25 | — | $4.0B | ||
| Q1 25 | — | $4.0B | ||
| Q4 24 | — | $4.2B | ||
| Q3 24 | — | $4.2B | ||
| Q2 24 | — | $3.9B |
股东权益DXCMPR
| Q1 26 | $2.7B | — | ||
| Q4 25 | $2.7B | $10.3B | ||
| Q3 25 | $2.7B | $10.0B | ||
| Q2 25 | $2.6B | $9.5B | ||
| Q1 25 | $2.3B | $9.4B | ||
| Q4 24 | $2.1B | $9.1B | ||
| Q3 24 | $2.0B | $9.0B | ||
| Q2 24 | $2.4B | $8.3B |
总资产DXCMPR
| Q1 26 | $6.3B | — | ||
| Q4 25 | $6.3B | $17.9B | ||
| Q3 25 | $7.5B | $17.3B | ||
| Q2 25 | $7.3B | $17.5B | ||
| Q1 25 | $6.8B | $17.1B | ||
| Q4 24 | $6.5B | $16.9B | ||
| Q3 24 | $6.4B | $16.6B | ||
| Q2 24 | $6.8B | $15.4B |
负债/权益比DXCMPR
| Q1 26 | — | — | ||
| Q4 25 | — | 0.34× | ||
| Q3 25 | — | 0.35× | ||
| Q2 25 | — | 0.42× | ||
| Q1 25 | — | 0.43× | ||
| Q4 24 | — | 0.46× | ||
| Q3 24 | — | 0.47× | ||
| Q2 24 | — | 0.46× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $904.3M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | 2.66× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流DXCMPR
| Q1 26 | — | — | ||
| Q4 25 | $294.0M | $904.3M | ||
| Q3 25 | $659.9M | $766.5M | ||
| Q2 25 | $303.0M | $1.0B | ||
| Q1 25 | $183.8M | $898.0M | ||
| Q4 24 | $301.4M | $871.6M | ||
| Q3 24 | $199.5M | $954.4M | ||
| Q2 24 | $279.4M | $938.4M |
自由现金流DXCMPR
| Q1 26 | — | — | ||
| Q4 25 | $192.1M | — | ||
| Q3 25 | $579.4M | — | ||
| Q2 25 | $208.9M | — | ||
| Q1 25 | $96.8M | — | ||
| Q4 24 | $176.8M | — | ||
| Q3 24 | $88.3M | — | ||
| Q2 24 | $213.3M | — |
自由现金流率DXCMPR
| Q1 26 | — | — | ||
| Q4 25 | 15.3% | — | ||
| Q3 25 | 47.9% | — | ||
| Q2 25 | 18.1% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 15.9% | — | ||
| Q3 24 | 8.9% | — | ||
| Q2 24 | 21.2% | — |
资本支出强度DXCMPR
| Q1 26 | — | — | ||
| Q4 25 | 8.1% | — | ||
| Q3 25 | 6.7% | — | ||
| Q2 25 | 8.1% | — | ||
| Q1 25 | 8.4% | — | ||
| Q4 24 | 11.2% | — | ||
| Q3 24 | 11.2% | — | ||
| Q2 24 | 6.6% | — |
现金转化率DXCMPR
| Q1 26 | — | — | ||
| Q4 25 | 1.10× | 2.66× | ||
| Q3 25 | 2.33× | 12.94× | ||
| Q2 25 | 1.69× | 5.01× | ||
| Q1 25 | 1.74× | 2.73× | ||
| Q4 24 | 1.99× | 4.02× | ||
| Q3 24 | 1.48× | 2.47× | ||
| Q2 24 | 1.95× | 3.99× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DXCM
暂无分部数据
PR
| Crude Oil | $1.0B | 87% |
| Natural Gas Liquids Reserves | $145.1M | 12% |
